Navigation Links
Countervail Corporation Receives Additional $5.4 Million from BARDA For Continued Development of Medical Countermeasure to Nerve Agents
Date:11/12/2013

Charlotte, NC (PRWEB) November 12, 2013

CHARLOTTE, NC, Nov 8, 2013 /PRWeb/ -- Countervail Corporation announced today the Department of Health and Human Services (HHS), through the Biomedical Advanced Research and Development Authority (BARDA), has exercised a contract option for an additional $5.4 million for the further development of galantamine hydrobromide, under the trade name AverTox™, as a medical countermeasure to the toxic effects of organophosphorus based nerve agents. BARDA exercised the option following an inter-agency In Process Review of the performance milestones completed by the company during the first phase of the contract.

“AverTox™ has shown favorable laboratory results as a neuroprotectant against the toxic effects of nerve agents such as Sarin and VX. We are pleased to have the continued support from BARDA for the development of this promising drug,” said CEO and President of Countervail, Bill Basinger.

Countervail has the distinction of being the first company awarded a contract with BARDA for the development of a medical countermeasure to a chemical threat. To date, the company has been awarded $10.7 million under the five-year $24.9 million contract.

About Countervail Corporation
Countervail Corporation, formed in 2007, is an early stage biopharmaceutical company focused on the development and commercialization of products that protect our military and civilian populations from chemical and biological threats.

This project has been funded in whole or in part with federal funds from the Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services, under Contract No: HHSO100201100030C

Read the full story at http://www.prweb.com/releases/2013/11/prweb11317764.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1

Related medicine news :

1. Agein Corporation, a Leading Anti-Aging Company, Responds to Research Showing More Men Turning to Cosmetic Surgery to Increase Work Opportunities
2. Rich Products Corporation Streamlines their Production Process with Seamless Workflow, Media Asset Management and Online Proofing
3. ZeptoMetrix Corporation (ZMC) in Collaboration with CytoSignet, Inc. to Offer Proactive, Patented* and Extensive Bed Bug Detection Products
4. Divine Corporation, Developers of Divine 9 Personal Lubricants with Carragel, Changes the Company Name to CarraShield Labs, Inc.
5. Agein Corporation Congratulates Wal-Mart & Target for Ban of Chemicals in Products
6. E-Waste Event, Hosted by: Miller Recycling Corporation
7. Pionetics® Corporation Signs Rayne of Amarillo as a New LINX® Distributor
8. Vidacare Corporation Launches New iOS App for OnControl Powered Bone Access System
9. Evaero Corporation to Participate in National Conference on Addiction Disorders
10. Domtar Corporation to Locate North American Operations Center in Pitt County, NC
11. Scientific Technologies Corporation Featured on 21st Century Health Television Series
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... today announced its strategic partnership with Connance, a healthcare industry leader providing ... companies’ proven, proprietary technology combine to provide health systems, hospitals and ambulatory ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media ... give their videos a whole new perspective by using the title layers in ... Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/25/2016)... ... 2016 , ... Austin residents seeking Mohs surgery services, can now turn to ... Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to ... fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... June ... about the dangers associated with chronic pain and the benefits of holistic treatments, ... individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... p.m. (Eastern Daylight Time). As previously announced ... into a definitive merger agreement under which Jazz Pharmaceuticals ...
(Date:6/24/2016)... HILL, N.C. , June 24, 2016 /PRNewswire/ ... healthcare decisions and regulators/payers have placed more emphasis ... new environment, patient support programs in the pharmaceutical ... for patients, medications. Consequently, pharmaceutical companies are focusing ... ensure they are providing products and services that ...
(Date:6/24/2016)...   Bay Area Lyme Foundation , collaborating ... for Tick Borne Illness , Harvard Medical School ... Medicine, University of California, Berkeley, and the Veterans ... finalists of Lyme Innovation , the first ... scientists, clinicians, researchers, entrepreneurs, and investors from several ...
Breaking Medicine Technology: